China Shineway Pharmaceutical Group (CSWYY) Stock Price, News & Analysis

Company Overview

China Shineway Pharmaceutical Group Co., Ltd. is a China-based veterinary pharmaceutical company primarily engaged in the research, development, production and distribution of veterinary vaccines and biologics. The company’s product portfolio includes live attenuated vaccines, inactivated bacterins, recombinant subunit vaccines and diagnostic reagents designed to prevent and control infectious diseases in livestock, poultry and aquaculture. In addition to vaccines, Shineway manufactures veterinary antibiotics, feed additives and disinfectants for animal health management.

Headquartered in Langfang City, Hebei Province, China Shineway operates multiple production facilities across Hebei, Sichuan and Shandong provinces. These facilities adhere to Good Manufacturing Practices (GMP) standards and are equipped for large-scale fermentation, antigen purification and aseptic filling. The company’s integrated supply chain covers raw material sourcing, in-house vaccine formulation, quality control testing and nationwide distribution networks.

Founded in 1994, China Shineway has grown to become one of China’s leading suppliers of veterinary biologics, serving both domestic and international markets. The company’s export footprint extends to Southeast Asia, the Middle East, Africa and Latin America, where its vaccines are used in government-led animal disease control programs as well as private veterinary practices. China Shineway also collaborates with research institutes and provincial animal health centers on epidemiological surveillance and vaccine efficacy trials.

Research and development is a core focus for China Shineway. The company maintains R&D centers dedicated to pathogen strain isolation, antigen engineering and novel delivery systems. By leveraging molecular biology and immunology platforms, China Shineway aims to expand its pipeline of next-generation vaccines targeting emerging and re-emerging animal diseases. Its ongoing investments in innovation underpin efforts to enhance vaccine safety, efficacy and production efficiency.

Key Stats

• Today's Range: C$19.25 to C$19.25
• 50-Day Range: C$18.94 to C$19.25
• 52-Week Range: C$18.53 to C$19.25
• Volume: N/A
• Average Volume: 200 shs
• Market Capitalization: N/A
• P/E Ratio: 1.13
• Dividend Yield: 22.78%
• Price Target: N/A
• Consensus Rating: N/A

China Shineway Pharmaceutical Group Stock Analysis - MarketRank™

China Shineway Pharmaceutical Group scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for China Shineway Pharmaceutical Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of China Shineway Pharmaceutical Group is 1.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 43.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of China Shineway Pharmaceutical Group is 1.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.88.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

China Shineway Pharmaceutical Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in China Shineway Pharmaceutical Group has recently increased by 1.08%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

China Shineway Pharmaceutical Group pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

China Shineway Pharmaceutical Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of China Shineway Pharmaceutical Group is 25.79%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: N/A

News Sentiment

China Shineway Pharmaceutical Group has a news sentiment score of -0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for China Shineway Pharmaceutical Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, China Shineway Pharmaceutical Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.01% of the stock of China Shineway Pharmaceutical Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CSWYY
• CIK: N/A
• Web: www.shineway.com
• Phone: 86 31 1880 30066
• Fax: N/A
• Employees: 3,533
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.13
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A